Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    

3SBIO INC. (ADR)
Mes dernières consult.
Most popular
Report
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD541993Chairman, President & Chief Executive Officer
Wei hong Xiao482016Chief Operating Officer
Bo Tan, MBA442009Chief Financial Officer & Executive Director
Zhenping Zhu MD, PhD-2017CSO, President-Research & Development
Dong Mei Su, PhD462012Executive Director
Bin Huang, MBA561993Executive Director & Vice President
Dong Liu, MBA442014Non-Executive Director
Tian Ruo Pu, MBA482014Independent Non-Executive Director
David R. Parkinson MD, PhD672014Independent Non-Executive Director
Jun Ma, PhD542014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,532,313,570 1,091,142,120 43.1% 0 0.0% 43.1%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 621,512,360 24.5%
Jing Lou, MD, PhD 599,367,030 23.6%
Bo Tan, MBA 116,849,920 4.60%
OppenheimerFunds, Inc. 81,043,500 3.19%
Dan Lou 62,001,010 2.44%
The Vanguard Group, Inc. 34,111,500 1.34%
Bin Huang, MBA 32,197,350 1.27%
Dong Mei Su, PhD 25,585,630 1.01%
JF Asset Management Ltd. 23,898,295 0.94%
BlackRock Fund Advisors 22,755,500 0.90%
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.25386000
Fax : +86.24.25811821
Web : www.3sbio.com
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
3SBIO INC. (ADR)5 152
BIOGEN18.26%65 516
CSL LIMITED43.07%49 706
ALEXION PHARMACEUTICALS-11.69%24 039
GRIFOLS SA33.08%18 690
BIOMARIN PHARMACEUTICAL0.18%14 575
CHONGQING ZHIFEI BIOLOGICAL PRDCT CO LTD--.--%6 794
3SBIO INC107.63%5 152
ABCAM PLC30.64%2 732
BOYA BIO-PHARMACEUTICAL GROUP CO LTD--.--%1 827
HUGEL INC--.--%1 754
BIOTEST AG32.11%936
ANIKA THERAPEUTICS INC11.87%799
PROMETIC LIFE SCIENCES INC.-37.72%793
PHARMA MAR SA-11.81%630
WILSON THERAPEUTICS AB103.74%357
SYROS PHARMACEUTICALS INC9.38%356
CHEMOCENTRYX INC-5.14%341
KADMON HOLDINGS INC-34.21%277
STRONGBRIDGE BIOPHARMA PLC164.58%261
CO DON AG272.94%234
Connections : 3SBio Inc. (ADR)
Beingmate Group Co. Ltd.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd.
CFA Institute
Zhaopin Ltd.
Excel Partner Holdings Ltd.
Shenzhen Baishitong Technology Development Co., Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Biosensors International Group Ltd.
Collected Mind Ltd.
CITIC Industrial Investment Group Corp. Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
UTStarcom, Inc.
Liaoning Sunshine Science & Technology Development Co. Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Ample Harvest Investments Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Hong Kong Sansheng Ltd.
The Multiple Myeloma Research Foundation, Inc.
© 2017 People , Fundamentals and Ownership